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        BM-derived immature IgM  +   B cells can ma-
ture in the BM itself or migrate to the spleen 
and mature into follicular and marginal zone B 
cells (  1  –  7  ). Maturation proceeds through short-
lived transitional B cell stages (  2, 3, 8  ), and sev-
eral specifi  c signaling receptors and transcription 
factors are involved in this process ( 1  –  6  ). Newly 
formed B cells that have recently emerged from 
the BM represent the T1 transitional stage of 
development in which cells express high levels 
of CD24 and AA4.1 and low levels of CD23, 
CD21, and IgD. At the T2 stage, cells acquire 
the ability to recirculate and to express higher 
levels of CD23, CD21, and IgD, and they are 
capable of maturing into either marginal zone 
or follicular B cells (  2, 5, 9  ). The T3 subset may 
represent a specifi  c follicular B cell population 
that has recently matured (  3  ), but it has also 
been recently suggested that T3 cells may rep-
resent anergic B cells (  10  ). 
  In several systemic and organ-specifi  c infl  am-
matory disorders, ectopic neolymphoid follicles, 
which are sometimes called tertiary lymphoid 
tissue, are induced by the mobilization of B cell 
progenitors from the BM to the periphery (  11  –
  15  ). Interestingly, although the BM functions 
as a primary lymphoid organ, it may also serve 
as a secondary lymphoid organ in which activa-
tion of B cells may occur in response to circu-
lating pathogens (  7, 16  ). Although   >  80% of the 
body  ’  s B cells are located in gut-associated lym-
phoid tissues (GALTs) (  17, 18  ), it is unknown 
whether these cells are derived from the activa-
tion of recirculating B cells or if they include 
novel populations of naive B cells that specifi  -
cally home to these sites. 
  The mucosal immune system is constitutively 
exposed to a wide spectrum of commensal mi-
crofl  ora (  18  –  21  ). The eff  ecter lymphoid com-
ponent of GALT includes scattered lymphocytes 
throughout the lamina propria of the small and 
large intestine. The inductive sites consist of 
organized lymphoid tissues, such as Peyer  ’  s 
patches (PPs), which are formed in a lympho-
toxin (LT)-     dependent manner (  17, 19  –  22  ). 
Because the small intestine represents a major 
source of IgA  +   plasma cells, the majority of stud-
ies on intestinal B cells have focused on small 
intestinal IgA  +   plasma cells (  17  –  20, 23  –  28  ). Three 
pathways have been identifi  ed for small intestinal 
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    Over 80% of the body  ’  s activated B cells are located in mucosal sites, including the intes-
tine. The intestine contains IgM  +   B cells, but these cells have not been characterized phe-
notypically or in terms of their developmental origins. We describe a previously unidentifi  ed 
and unique subset of immunoglobulin M  +   B cells that present with an AA4.1       CD21       CD23        
major histocompatibility complex class II  bright   surface phenotype and are characterized by a 
low frequency of somatic hypermutation and the potential ability to produce interleukin-
12p70. This B cell subset resides within the normal mucosa of the large intestine and 
expands in response to infl  ammation. Some of these intestinal B cells originate from the 
AA4.1  +   immature B2 cell pool in the steady state and are also recruited from the recircu-
lating naive B cell pool in the context of intestinal infl  ammation. They develop in an anti-
gen-independent and BAFF-dependent manner in the absence of T cell help. Expansion of 
these cells can be induced in the absence of the spleen and gut-associated lymphoid tis-
sues. These results describe the existence of an alternative pathway of B cell maturation in 
the periphery that gives rise to a tissue-specifi  c B cell subset. 1344 A NOVEL B CELL POPULATION   | Shimomura et al. 
were CD24  intermediate  CD62L       CD1d  +   and did not express B1 
cell markers (CD43, CD11b, and CD5;   Fig. 1 E   and Fig. S1). 
The intestinal B cells proliferated in vitro in the response to 
BCR ligation, as well as LPS stimulation (  Fig. 1 F  ). These 
fi  ndings defi  ne a previously unidentifi  ed, unique B cell subset 
that exists in normal and infl  amed large intestine. 
  Intestinal B cells are derived from AA4.1  +   immature 
and transitional B cells 
  Intestinal B cells with their unique phenotype could either 
represent a naive or an activated B cell population. These 
cells could develop in the intestine in situ from uncommitted 
lymphoid progenitors, or they may be derived from newly 
formed B cells that not only seed the spleen but also home 
to the intestine, or they could represent a population that dif-
ferentiates from recirculating follicular phenotype B cells or 
from B1 B cells. The rapid expansion of intestine-specifi  c 
CD21       CD23        B cells in the DSS colitis model provided us 
an opportunity to more closely examine how these cells ex-
pand either by proliferation of existing cells or by enhanced 
recruitment or development from progenitors. Because intes-
tinal B cells share some phenotypic features with T1 B cells, 
but the latter also express AA4.1, a marker for recently gener-
ated B cells, (  34  ), we next examined AA4.1 expression on 
intestinal B cells. Less than 10% of intestinal B cells expressed 
AA4.1 (  Fig. 2 A  ). Unlike AA4.1        intestinal B cells, the AA4.1  +   
intestinal B cells consisted of two subsets, T1-like CD23        
and T2-like CD23  +   B cells (  Fig. 2 A  ). To examine whether 
AA4.1       CD21       CD23        intestinal B cells could potentially 
mature from the AA4.1  +   immature B cells, in vivo BrdU pulse 
labeling was performed as previously described (  35  ). In the 
AA4.1  +   IgM  +   population from the normal large intestine of 
WT mice, BrdU  +   B220  +   cells were observed on both day 2 
and 6 after the initial BrdU injection (  Fig. 2 B  , top). In con-
trast, BrdU  +   B220  +   cells were not detectable at day 2 in the 
AA4.1       IgM  +   population, but became clearly detectable at day 6 
(  Fig. 2 B  , bottom). Similar fi  ndings were also observed in the 
infl  amed intestine after DSS treatment (Fig. S2). To confi  rm 
whether AA4.1  +   immature B cells actually possess the abil-
ity to diff  erentiate into intestinal IgM  +   B cells, we purifi  ed 
AA4.1  +   B220  +   B cells from the spleen of GFP transgenic 
mice, and then transferred them (5   ×   10  6  ) intravenously into 
WT mice, with or without induction of DSS colitis. GFP  +   
IgM  +   B cells were detected in the colon and spleen of both 
recipient mouse groups (  Fig. 2 C  , right). The reconstituted 
GFP  +   IgM  +   B cells in the spleen expressed CD21 and CD23 
(  Fig. 2 D  ). In contrast, the GFP  +   IgM  +   B cells reconstituted 
in the colon did not express CD21 and CD23 (  Fig. 2 D  ). 
  Naive follicular B cells, which mature from AA4.1  +   im-
mature B cells, have the ability to recirculate in search of an-
tigens (  36  ). Therefore, we next examined the involvement of 
recirculating naive B cells in the development of intestinal B 
cells. To do so, we purifi  ed IgD  high   naive recirculating B cells 
from the spleen of GFP transgenic mice and transferred them 
(5   ×   10  6  ) intravenously into WT mice with or without in-
duction of DSS colitis. 4 d after cell transfer, donor-derived 
plasma cell development. Approximately half of all IgA  +   
plasma cells in the intestine may originate from peritoneal B1 
cells, whereas the remainder may be either derived from acti-
vated B cells that migrate from organized lymphoid tissues 
such as PPs, or originate from naive B cells through a distinct 
pathway for gut-primed B cells (  17  –  20, 23  –  28  ). In addition 
to plasma cells, IgM  +   B cells also exist within the normal in-
testine and signifi  cantly increase within large intestinal muco-
sal tissues during infl  ammatory responses (  29  –  32  ). However, 
the phenotypic and developmental properties of IgM  +   B cells 
in the intestine have not yet been fully explored. 
  We describe a previously unidentifi  ed, intestine-specifi  c, 
IgM  +   B cell subset that is characterized by an AA4.1       CD21      
CD23       MHCII  bright   phenotype, by a low frequency of somatic 
hypermutation (SHM), and by the potential ability to pro-
duce IL-12p70 after exposure to microbes. These cells appear 
to exist in a unique preactivated state, as indicated by the very 
high expression levels of MHC class II on these cells. This 
intestinal IgM  +   B cell subset may originate from AA4.1  +   im-
mature transitional B cells in the steady state, and may be sig-
nifi  cantly increased in the infl  amed intestine after recruitment 
from the recirculating naive B cell pool. 
    RESULTS   
  Identifi  cation of a unique AA4.1       CD21       CD23       IgM  +   B cell 
subset in the large intestine 
  IgM  +   B cells have been described in the large intestine, and 
these cells expand signifi  cantly and form B cell clusters in 
certain disease states involving intestinal infl  ammation (  29  –  32  ). 
We herein demonstrate that the majority of IgM  +   B cells in 
the large intestine of WT mice exhibit a unique surface phe-
notype that is distinct from that of recirculating splenic and 
mesenteric LN (MLN) B cells. In contrast to splenic, MLN, 
and PP B cells, the majority of intestinal IgM  +   B cells are 
CD21       CD23       IgD  low   (  Fig. 1 A  ). Because a signifi  cant in-
crease in intestinal B cells has been well documented in sev-
eral colitis models (  29  –  32  ), we next examined the phenotype 
of IgM  +   B cells from the inflamed intestine of three coli-
tis models, including TCR     KO mice (Th2 cell  –  dependent 
chronic colitis), IL-10 KO mice (Th1 cell  –  dependent chronic 
colitis), and dextran sodium sulfate (DSS)  –  induced acute coli-
tis (  29, 32, 33  ). As previously demonstrated (  29, 32  ), a sig-
nifi  cant increase in IgM  +   B cells was observed in the infl  amed 
intestine of TCR     KO mice and IL-10 KO mice (  Fig. 1 B  ). 
Interestingly, we found that in the DSS colitis model intesti-
nal B cell expansion was specifi  cally induced during the re-
covery phase (after termination of DSS treatment), but not 
during the acute phase when DSS was being administered. In 
comparison to day 0 (normal mucosa), the proportion as well 
as the absolute numbers of IgM  +   cells in the large intestine 
were slightly decreased at day 4 (acute phase), but increased 
signifi  cantly at day 8 (during the recovery phase) of DSS coli-
tis (  Fig. 1, B and C  ). Like normal intestinal IgM  +   B cells, the 
majority of intestinal IgM  +   B cells in these colitis models 
were also of the CD21       CD23       IgD  low   phenotype (  Fig. 1 D  ). 
In addition, intestinal B cells from normal and infl  amed mucosa JEM VOL. 205, June 9, 2008 
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matory stimuli induce the recruitment of IgD  high   naive recir-
culating B cells to the intestine, resulting in the signifi  cant 
increase in IgM  +   B cells within the infl  amed intestine. 
  Intestinal B cells exhibit a unique activated phenotype 
  Because some intestinal B cells originate from the recirculating 
naive B cell pool, particularly under infl  ammatory conditions, 
we next tested whether the intestinal B cells phenotypically 
resemble naive or activated B cells. The expression of several 
activation markers (  16  ) was analyzed. Interestingly, the IgM  +   
GFP  +   IgM  +   B cells were detected in the spleen of both re-
cipient mouse groups (  Fig. 2 E  , left). In contrast, GFP  +   IgM  +   
B cells were detectable in the infl  amed colon (DSS-treated), 
but not in normal colon (  Fig. 2 E  , right). In addition, the re-
constituted GFP  +   IgM  +   B cells in the spleen had a CD21  +   
CD23  +   phenotype, whereas the GFP  +   IgM  +   B cells in the colon 
were CD21       CD23        (  Fig. 2 F  ). These data, together with 
  Fig. 2   (  B and C)   and Fig. S2, support the view that AA4.1        
intestinal B cells directly or indirectly mature from AA4.1  +   
immature B cells in the steady state and that intestinal infl  am-
    Figure 1.         Identifi  cation of a unique IgM  +   B cell subset in the large intestine.   (A) Expressions of IgM versus IgD, CD21, or CD23 of the cells from 
colon, spleen (SP), MLN, and PP of WT mice are shown. (B) For DSS colitis, intestinal infl  ammation was induced by administration of 4% DSS in drinking 
water, and the treatment was terminated by changing DSS water to normal water at day 4. (top) Proportions of IgM versus CD3    -expressing cells in the 
large intestine from normal mice (Day 0,   n   = 21) and DSS-induced colitis mice (Day 4 [acute phase],   n   = 11; Day 8 [recovery phase],   n   = 24). (bottom) Pro-
portions of IgM versus CD3    -expressing cells in the large intestine of chronic colitis models, TCR     KO mice (  n   = 3), and IL-10 KO mice (  n   = 3). (C) Abso-
lute numbers of IgM  +   cells in the large intestine of DSS colitis at day 0, 4, 8, and 30 are shown. (D) Expressions of IgM versus CD23, CD21, or IgD on the 
cells from large intestine of three colitis models (DSS colitis, TCR     KO mice, and IL-10 KO mice) are shown. The data are representative of 3  –  11 individual 
experiments. (E) Expression of several surface makers on the gated IgM  +   B220 +   cells from the large intestine of DSS at day 8 (solid lines) and from spleen 
(dot lines) is shown. The data are representative of 11 individual experiments. (F) Proliferative responses of purifi  ed B cells (  >  95% are IgM  +  ) from the co-
lon (shaded bars) and spleen (open bars) to stimulation without (No) or with LPS (5   μ  g/ml) or F(ab  ’  )  2   anti-Ig    Abs  (anti-   ; 50   μ  g/ml) are shown. The re-
sults represent the mean   ±   the SEM of triplicate data from three individual mice.     1346 A NOVEL B CELL POPULATION   | Shimomura et al. 
intestinal B cells were characterized by remarkably high ex-
pression levels of MHC class II in comparison to splenic B 
cells (  Fig. 3 A  ). The expression levels of MHC class II were 
comparable on B cells from normal and infl  amed intestine 
(  Fig. 3 A  ). In addition, a slight increase in the expression of 
CD69 was observed on the intestinal B cells in comparison to 
splenic B cells (  Fig. 3 A  ). In contrast, no signifi  cant up-regula-
tion of Fas, PNA, CD80, or CD86 was found on the intestinal 
B cells. Therefore, it is possible that intestinal B cells repre-
sent a unique activated B cell population that is MHCII  bright  , 
CD69  intermediate  , Fas  low  , PNA  low  , CD80       , and CD86  low  . To eluci-
date whether the phenotype of intestinal B cells represents a 
response to an intestinal pathogen, and to determine if these 
cells can be further activated by pathogens, we examined 
intestinal B cells after infection with   Citrobacter rodentium  . 
This infection did not induce the expression of Fas or PNA 
on intestinal B cells (  Fig. 3 B  ). These data suggest that the 
MHCII  bright   intestinal IgM  +   B cell population is not elicited 
by a known intestinal pathogen, and these cells may represent 
a unique preactivated B cell population. 
  Functional property of IgM  +   B cells in the large intestine 
  Because the intestine is a major source of IgA-plasma cells 
(  17  –  20, 23  –  25  ), the diff  erentiation of activated intestinal B 
cells into IgA plasma cells was next investigated. Interestingly, 
although IgM  +   B cells were markedly increased in the in-
fl  amed mucosa during the recovery phase of DSS colitis, no 
signifi  cant increase in the proportion of B220       IgA  +   or CD138  +   
plasma cells was observed at this site (  Fig. 4 A  ). ELISPOT assay 
also showed that the absolute number of IgA-secreting cells 
among total intestinal cells decreased during the recovery phase 
of DSS colitis (day 8;   Fig. 4, B and C  ). In addition, expression 
of activation-induced deaminase an enzyme required for class 
switch recombination and SHM (  37, 38  ) was slightly lower in 
the IgM  +   B cells of the large intestine when compared with 
splenic IgM  +   B cells (  Fig. 4 D  ). To analyze the frequency of 
SHM, genomic DNA was isolated from purifi  ed IgM  +   B cells 
from the large intestine and the spleen of WT mice and sub-
jected to PCR/DNA sequence analysis using a primer set that 
amplifi  es rearranged V    4-J    5 light chain segments of genomic 
DNA (  39  ). There was no signifi  cant restriction of V    4 sub-
family usages between intestinal and splenic IgM  +   B cells. In-
terestingly, the frequency of SHM within the V    4 segments 
was signifi  cantly lower in intestinal IgM  +   B cells compared 
with splenic IgM  +   B cells (  Fig. 4, E and F  ). These fi  ndings 
suggest that IgM  +   B cells do not appear to contribute to IgA-
producing plasma cells in the large intestine, and they are char-
acterized by the low frequency of SHM. 
  Several recent studies have suggested that, like T cells, B 
cells also possess the ability to produce several kinds of cytokines 
    Figure 2.         Direct maturation of AA4.1  +   immature B cells to AA4.1            
intestinal B cells.   (A) Intestinal infl  ammation was induced by adminis-
tration of 4% DSS in drinking water and the treatment was terminated by 
changing the DSS-containing water to normal water at day 4. Expression 
of AA4.1 versus B220 (top) in total large intestinal cells (day 8) and CD23 
versus IgM expression on the gated AA4.1  +   B220 +   cells (bottom;   n   = 12) is 
shown. (B) 1 mg BrdU was administered (intraperitoneally) into intact WT 
mice twice with a 24-h interval between injections, and the mice were 
killed at 2 and 6 d after initial BrdU injection. The B220 versus BrdU ex-
pressions on the gated AA4.1  +   (top) or AA4.1        (bottom)  IgM +   cells  from 
large intestine are shown. The data are representative of three individual 
experiments. (C and D) Purifi  ed AA4.1  +   B220 +   B cells from the spleen of 
GFP transgenic mice (left) were intravenously transferred into WT mice 
with or without prior DSS exposure. 6 d after cell transfer, the recipient 
mice were killed. GFP- and IgM-expressing B cells in the recipient colon 
and spleen were identifi  ed (C). The expression of CD21 and CD23 versus 
IgM on the gated GFP  +   cells in the spleen and colon of recipient mice 
without DSS treatment is shown in D. The data are representative of three 
to six individual recipients/group. (E and F) Purifi  ed IgD  high   B cells from the 
spleen of GFP transgenic mice were intravenously transferred into WT 
mice that had being treated without (top) or with DSS (bottom). 4 d after 
cell transfer, the recipient mice were killed. The expressions of GFP versus 
IgM in recipient spleen (left) and colon (right) are shown in (E). The ex-
pressions of CD21 or CD23 on the gated GFP  +   cells from the spleen (left) 
and large intestine (right) of DSS treated mice are shown in (F). The data 
are representative of three individual recipients.     
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from the large intestine, but not the spleen, of WT mice 
produce a large amount of lL-12p70 in response to CpG 
(  Fig. 4, G and H  ). 
  Antigen-independent polyclonal expansion of intestinal 
CD21       CD23        B cells 
  The intestine is constitutively exposed to a wide spectrum of 
enteric microorganisms (  19  ). Therefore, we examined the clon-
ality of B cells in the large intestine by analyzing the VDJ re-
gion of IgM heavy chains (VHJ558 and VHQ52) to test 
whether some specifi  c enteric (microbial) antigens cause the 
expansion of intestinal B cells. There was no restricted diver-
sity of the BCR repertoire of VHJ558 or VHQ52 within the 
B cells from the normal intestine (Fig. S3 and Fig. S4). Inter-
estingly, a similar polyclonal pattern was also observed in B 
cells from the infl  amed intestine of DSS colitis (Fig. S3 and 
Fig. S4). These fi  ndings suggest that the intestinal IgM  +   B 
cells using VHJ558 and VHQ52, which together account for 
65% of the BCR repertoire (  44  ), expand polyclonally. 
  To further test the antigen specifi  city of intestinal B cell 
development, we generated IghelMD4 Tg x RAG1 KO 
mice; these mice contain only a monoclonal B cell popula-
tion that expresses a restricted BCR specifi  c for hen egg lyso-
zyme. IgM  +   B cells were still detected in the intestines of 
these mice in the absence of any infl  ammatory stimulus, and 
a marked expansion of these B cells occurred in the infl  amed 
mucosa during the recovery phase from DSS-induced colitis 
(  Fig. 5 A  ). As seen in WT mice, the expanded IgM  +   B cells 
formed clusters within the infl  amed mucosa (  Fig. 5 B  ). In ad-
dition, the majority of IgM  +   B cells were of the CD21       CD23        
phenotype (  Fig. 5 C  ). These fi  ndings suggest that antigen/BCR 
interactions may not be essential for intestinal CD21       CD23        
B cell development. It however cannot be ruled out that 
some self-antigen that cross-reacts with hen egg lysozyme ex-
ists. To further explore the role of antigens and the BCR, we 
investigated KO mice defi  cient in Bruton  ’  s tyrosine kinase 
(Btk) or Lyn, both of which play a crucial role in the BCR 
signaling cascade (  45  –  47  ). Interestingly, CD21       CD23       IgM  +   
B cells were detectable at normal levels in the intestines of 
these mice in the absence of DSS (  Fig. 5 D  ), and they were 
signifi  cantly increased within the infl  amed intestine during 
the recovery phase of DSS colitis (  Fig. 5 E  ). 
  T cell help is not required for intestinal CD21       CD23        B cell 
development or expansion 
  Interestingly, expansion of intestinal B cells after an infl  am-
matory stimulus resulted in the formation of B cell clusters 
with a unique pattern of T cell localization (  Fig. 5 F  ); T cells 
were present around B cell clusters rather than in well-
defi  ned T cell areas, as normally seen in resident organized 
lymphoid tissues such as colonic patches (  Fig. 5 F  ) (  48  ). In 
addition, follicular dendritic cells (FDCs) were not detectable 
within the B cell clusters, whereas scattered FDCs were nor-
mally present within the follicles of organized lymphoid tis-
sues (  Fig. 5 F  ). Therefore, we next examined the role of T 
cells during intestinal B cell development by using TCR         
(  40  –  43  ). We used real-time PCR to primarily screen B cells 
stimulated with ligands for pattern recognition receptors 
(including ligands for TLR 2, 4, 5, 7, and 9), and found that IL-
12p35 mRNA expression was specifi  cally induced in intestinal 
B cells after stimulation with CpG (unpublished data). Indeed, 
fl  ow cytometric analysis clearly showed that IgM  +  B220  +   B cells 
    Figure 3.     Unique activated status of intestinal IgM  +   B cells.  
(A) Expressions of IgM versus MHC class II, CD69, Fas, PNA, CD80, or CD86 in 
cells of the spleen and colon from WT mice (Day 0) and WT mice during 
recovery phase of DSS colitis (Day 8) are shown. The data are representa-
tive of three individual mice. (B) Mice were infected with   C. rodentium  
and killed 6 and 10 d after infection. Expressions of IgM versus PNA or Fas 
on cells from the normal colon (left) and the infected colon (right) are 
shown. The data are representative of three individual mice/group. Repre-
sentative expression patter was observed on the intestinal B cells 6 d after 
infection (not depicted).     1348 A NOVEL B CELL POPULATION   | Shimomura et al. 
double KO (DKO) mice that have no TCR         or TCR  	       T 
cells. Just as was seen in WT mice, CD21       CD23        B cells 
represented the majority of IgM  +   B cells in the intestine of 
TCR         DKO mice (  Fig. 5 G  ). Interestingly, intestinal B cells 
were signifi  cantly increased in TCR         DKO mice as com-
pared with WT mice both in the absence of infl  ammation and 
under infl  ammatory conditions (  Fig. 5 H  ). Large IgM  +   B cell 
clusters were also recognized in the inflamed intestine of 
TCR         DKO mice (  Fig. 5 I  ). These fi  ndings suggest that 
T cells are not required for intestinal CD21       CD23        B cell 
development in a state of health and during infl  ammation, 
but may contribute to the suppression of the development or 
recruitment of intestinal IgM  +   B cells. 
  Intestinal CD21       CD23        B cells develop in the absence 
of both the spleen and organized lymphoid tissues 
  The LT-    1    2 signaling cascade is required for the develop-
ment of GALT (  20  –  22  ). Because some intestinal IgA  +   plasma 
cells have been shown to be derived from GALT, particularly 
from PP (  17, 20, 23  ), we examined the role of GALT in 
CD21       CD23        B cell development by using LT     KO mice 
that lack GALT (  20  –  22  ). Interestingly, CD21       CD23        B cells 
were still detectable in LT     KO mice (  Fig. 6 A  ), and a marked 
expansion of these B cells was induced in the infl  amed intes-
tine after exposure to DSS (  Fig. 6, B and C  ). IgM  +   B cell 
clusters were still detectable in LT     KO mice (  Fig. 6 D  ). 
These fi  ndings indicate that intestinal CD21       CD23        B cells 
develop even in the absence of GALT, which is consistent 
with previous reports showing that naive B cells can directly 
migrate into the small intestinal mucosa through a pathway 
diff  erent from GALT-primed B cells (  24, 25  ). 
  Peripheral B cells complete their maturation through 
transitional stages in the spleen (  1  –  6, 8, 34  ). Like recirculat-
ing follicular B cells, intestinal AA4.1       CD21       CD23        B cells 
also appear to mature from AA4.1  +   immature B cells. There-
fore, to test the role of the splenic environment during intes-
tinal B cell development, we used splenectomized LT     KO 
mice in which both the spleen and GALT were absent. Like 
WT mice, the majority of intestinal B cells in splenectomized 
LT     KO mice were of the CD21       CD23        phenotype (  Fig. 6 
F  ), and a marked expansion of these B cells with cluster for-
mation was observed during the recovery from DSS colitis 
(  Fig. 6, C and E  ). These results indicate that neither the 
spleen nor GALT is required for the development of intesti-
nal CD21       CD23        B cells, and that in the absence of spleen, 
    Figure 4.     Large intestinal IgM  +   B cells are characterized by low 
frequency of SHM and by production of IL-12 in response to CpG. 
  (A) Expressions of IgA and CD138 versus B220 on large intestinal cells 
from day 0 (  n   = 6) and day 8 (  n   = 6) of DSS colitis are shown. 
(B and C) ELISPOT assay shows the number of IgA-secreting cells among 
total large intestinal cells at day 0 and 8 of DSS colitis (B). The data are 
summarized in C. (D) Expressions of activation-induced deaminase in 
purifi  ed B cells from the colon of day 0 (open bar,   n   = 16) and day 8 (gray bar, 
  n   = 15) after DSS treatment and from the spleen of day 0 (black bar, 
  n   = 8) are shown. *, P   <   0.1; **, P   <   0.05. (E) Analysis of sequences with 
mutations (splenic and colonic IgM  +   B cells of normal WT mice) is depicted 
by pie charts. Numbers outside of each pie chart are the number of mutations/
clone. The size of the wedge is proportional to the percentage of clones 
carrying that number of mutations. Inside each inner circle is the number 
of clones sequenced. Data from an individual spleen (as control) and two 
different normal large intestines are shown. (F) Mutation frequencies are 
calculated by the number of mutations per 10  4   bp from splenic and large 
intestinal IgM  +   B cells of WT mice. (G) Cells from the normal large intes-
tine and spleen of WT mice were stimulated with 1   μ  M CpG for 17 h, 
including a 7-h culture period with GolgiStop. The stimulated cells were 
subjected to surface staining for detection of IgM and B220 and intracel-
lular staining for detection of IL-12p70. Expression of IL-12p70 in the 
gated IgM  + B220 +   cell population is shown. (H) The mean percentage of 
IL-12  –  producing cells among IgM  +   B cells from the large intestine (  n   =  6) 
and spleen (  n   = 6) of WT mice is shown. *, P   <   0.001.     
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the intestinal B cells may be recruited from recirculating 
naive B cells that mature in the BM (  7  ) and/or from BM-
derived immature AA4.1 B cells. 
  Insuffi  cient evidence to suggest a linkage between 
intestinal CD21       CD23        B cells and B1 lineage cells 
  IgA  +   plasma cells in the small intestine have previously been 
demonstrated to originate from peritoneal B1 cells (  18, 23  ). 
Therefore, we sought to determine if CD21       CD23        B cells 
in the large intestine might be derived from B1 B cells. To 
test this possibility, RAG-1 KO mice were reconstituted 
with peritoneal CD11b  +   cells from WT mice, which include 
B1 cells and macrophages, and the mice were subsequently 
treated with DSS. Although CD11b  +   IgM  +   B1 cells could be 
recognized in the peritoneal cavity of the recipient RAG KO 
mice, no IgM  +   cells were detectable in the infl  amed intestine 
(  Fig. 7 A  ). We next examined IL-7 receptor      (IL-7R) KO 
mice in which the development of B2, but not B1, cells is 
impaired (  49, 50  ) and Rac2 (guanosine triphosphatase) KO 
mice that show the impaired development of B1 cells (  51  ). 
Only a few IgM  +   cells were detectable in the normal and in-
fl  amed intestine of IL-7R KO mice (  Fig. 7, B and C  ). In ad-
dition, no B cell clusters were observed in the infl  amed 
mucosa of IL-7R KO mice exposed to DSS (  Fig. 7 D  ). In 
contrast, there were similar numbers of IgM  +   B cells in the 
normal intestine between Rac2 KO and WT mice, and sig-
nifi  cant B cell expansion was observed in the infl  amed mu-
cosa of both mouse groups after exposure to DSS (  Fig. 7, B 
and C  ). These fi  ndings, together with the phenotype of in-
testinal B cells (CD11b       , CD5       , and CD43       ) shown in   Fig. 
1 E  , and the data from Btk KO mice, all suggest that the ma-
jority of IgM  +   B cells in the large intestine may originate from 
conventional B2 lineage cells. 
  Dependence of intestinal CD21       CD23        B cells on BAFF-R 
signaling cascade 
  The rapid expansion of intestinal B cells by DSS-induced intes-
tinal infl  ammation provided an opportunity to closely examine 
the molecular events involved in intestinal B cell development 
and/or recruitment. We therefore performed a real-time PCR-
based screening approach using purifi  ed intestinal IgM  +   B cells 
from day 0 (normal), 4 (acute colitis), and 8 (recovery phase of 
colitis with B cell expansion) of DSS colitis to analyze the ex-
pression of 276 molecules that have been demonstrated to play 
crucial roles in the genesis, diff  erentiation, maturation, apopto-
sis/survival, homing and activation of B cells (  1  –  6, 46, 47, 52, 
53  ). We found that receptor of B cell activation factor from the 
TNF family (BAFF-R) is specifi  cally up-regulated in intestinal 
B cells on day 8 as compared with day 4 and 0 (  Fig. 8 A  ). In 
contrast, intestinal IgM  +   B cells did not express BCMA (B cell 
maturation antigen) during the course of infl  ammation (  Fig. 8 
A  ). BAFF-R engagement promotes processing of NF-    B2 
    Figure 5.         Development of intestinal CD21           CD23            B cells through 
BCR-independent response without T cell help.   (A) Absolute number 
of IgM  +   cells in the large intestine from lghelMD4 tg x RAG1 KO mice at 
day 0 (normal, open bar;   n   = 10) and day 8 (recovery phase of DSS colitis, 
shaded bar;   n   = 10) are shown. (B) Colonic tissues from WT mice at day 8 
and from lghelMD4 tg x RAG1 KO mice at days 0 and 8 were subjected to 
immunohistochemical analysis for the detection of IgM  +   cells. The fi  nd-
ings are representative of   >  12 individual experiments. (C) Expressions of 
IgM versus CD21 or CD23 on the gated B220  +   cells of normal large intes-
tine (Day 0) from lghelMD4 tg x RAG1 KO mice are shown. (D) Expres-
sions of IgM versus CD21 or CD23 on the gated B220  +   cells from normal 
large intestine of Btk KO mice (  n   = 5) and Lyn KO mice (  n   = 5) are shown. 
(E) Absolute numbers of large intestinal IgM  +   cells from Btk KO and Lyn 
KO mice at day 0 (normal, open bar,   n   = 5) and day 8 of DSS colitis (re-
covery, solid bar,   n   = 5  –  7) are shown. (F) Infl  amed intestinal mucosa (Day 
8 of DSS colitis, top) and colonic patch within normal mucosa (bottom) 
of WT mice were subjected to immunohistochemical analysis for the 
detection of IgM (left), CD3 (middle), and FDC (right). (G) Expressions of 
IgM versus CD21 or CD23 on the gated B220  +   cells of the normal large 
intestine from TCR       DKO mice are shown. (H) Absolute numbers of 
IgM  +   cells in the large intestine of WR and TCR       DKO mice at day 0 
(normal, open bar,   n   = 5  –  7) and day 8 (recovery of DSS colitis, solid bar; 
  n   = 5  –  7) are shown. (I) Large intestinal tissues of TCR       DKO mice at day 
8 of DSS colitis were subjected to immunohistochemical analysis for the 
detection of IgM  +   cells. Statistical signifi  cances are indicated in by ** (P   <   
0.001). Bars, 100   μ  m.     
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the infl  amed mucosa were detectable in control (  Fig. 8 F  ) but 
not BAFF-R mutant mice (  Fig. 8 G  ). In addition, signifi  -
cantly enhanced apoptosis of intestinal B cells was observed 
in BAFF-R mutant as compared with control mice (  Fig. 8 
H  ), which is consistent with an important role of BAFF-R 
signaling in B cell survival (  54  –  59  ). In addition, immature 
AA4.1  +   B cells in the large intestine were signifi  cantly reduced 
in BAFF-R mutant mice as compared with control mice 
(  Fig. 8 I  ). These fi  ndings suggest that the BAFF-R  –  associated 
signaling pathway plays a crucial role in intestinal B cell develop-
ment and homeostasis. They are consistent with a role for 
BAFF-R in all B2 populations after the T1 stage and the ab-
sence of a role for BAFF-R in B1 B cells (  58, 60  ). 
    DISCUSSION   
  In this study, we have described a previously unidentifi  ed, 
intestine-specifi  c, IgM  +   B cell subset that is characterized by a 
unique AA4.1       CD21       CD23       MHCII  bright   surface phenotype, 
protein p100 to p52, which is dependent on NF-    B  –  inducing 
kinase (NIK) (  54, 55  ). Recent studies indicate that activation of 
the BAFF-R signaling cascade up-regulates Pim2 (a prosurvival 
kinase) and Bim (a BH3-only member of the Bcl-2 family) 
(  56  ), and that BAFF-R signaling is negatively regulated by an 
adaptor protein, Act1 (  57  ). Indeed, a signifi  cant up-regulation 
of NIK, Pim2, and Bim was observed in purifi  ed intestinal 
IgM  +   B cells during the recovery, but not the acute, phase of 
intestinal infl  ammation (  Fig. 8 A  ). In contrast, expression of 
Act-1 was signifi  cantly down-regulated in B cells during the 
course (both day 4 and 8) of this infl  ammation (  Fig. 8 A  ). In 
addition, enhanced processing of NF-    B2 protein p100 to p52 
in intestinal B cells was specifi  cally observed in the recovery 
phase of infl  ammation (  Fig. 8 B  ). 
  To further examine the role of the BAFF-R signaling 
cascade in intestinal CD21       CD23        B cell development, we 
analyzed BAFF-R mutant (A/WySnJ) and A/J (control) mice 
(  54  –  56, 58, 59  ). Interestingly, intestinal B cells exhibiting 
CD21       CD23        phenotype were significantly reduced in 
BAFF-R mutant mice as compared with control mice (  Fig. 8 
C  ). In addition, DSS-induced colitis failed to induce a signif-
icant expansion of IgM  +  CD21       CD23        B cells in BAFF-R 
mutant mice (  Fig. 8, D and E  ). Indeed, B cell clusters within 
    Figure 6.         Intestinal CD21           CD23            B cell development is indepen-
dent of spleen and organization lymphoid tissues.   Intestinal  infl  am-
mation was induced in WT (Day 0,   n   = 8; Day 8,   n   = 8) and LT     KO (Day 0, 
  n   = 5; Day 8,   n   = 5) and splenectomized LT     (SP[-]  LT   ; Day 0,   n   = 5; Day 
8,   n   = 5) mice. (A) Expressions of IgM versus CD21 or CD23 on large intes-
tinal cells from LT     KO mice are shown. (B) Proportions (IgM/CD3   )  in 
large intestinal cells at day 8 are shown. (C) Absolute numbers of large 
intestinal IgM  +   cells at day 0 (normal, open bar) and day 8 (recovery, 
shaded bar) are shown. (D and E) The infl  amed intestine from LT     KO  (D) 
and splenectomized LT     KO (E) mice were subjected to immunohisto-
chemical analysis for the detection of IgM  +   cells. (F) Expressions of IgM 
versus CD21 or CD23 on the gated B220  +   cells from the normal colon 
(Day 0) of splenectomized LT     KO mice are shown. Bars, 100   μ  m.     
    Figure 7.     Intestinal CD21           CD23            IgM  +   B cells are not associated 
with B1 lineage cell  . (A) RAG1 KO mice that had been reconstituted 
with peritoneal B1 cells from WT mice were treated with 4% DSS for 4 d 
and killed at day 8. The DSS-treated recipient mice show suffi  cient recon-
stitution of CD11b  low   IgM +   B 1 cells in the peritoneal cavity (PC, left), 
whereas no IgM  +   B cells are detectable in the infl  amed mucosa (LP, right) 
of these mice. The data are representative of four individual recipient 
mice. (B  –  D) Intestinal infl  ammation was induced in WT (Day 0,   n   = 6; Day 
8,   n   = 6), Rac2 KO (Day 0,   n   = 5; Day 8,   n   = 5), and IL-7R     KO (Day 0,   n   = 
5; Day 8,   n   = 5) mice by oral administration of 4% DSS for 4 d. Proportion 
(IgM/CD3    ) at day 8 (B) and absolute number of IgM  +   cells in the large 
intestine at day 0 (normal, open bar) and day 8 (recovery, shaded bar; 
C) are shown. The large intestine from IL-7R     KO mice at day 8 was sub-
jected to immunohistochemical analysis for detection of IgM  +   cells  (D). 
Presence of statistical signifi  cance (P   <   0.001) compared with day 8 WT 
mice is indicated by **. Bars, 100   μ  m.     JEM VOL. 205, June 9, 2008 
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    Figure 8.     Requirement of BAFF-R  –  mediated signaling for intestinal CD21           CD23            B cell development.   (A) Expressions of BAFF signaling-related 
molecules in purifi  ed B cells from the large intestine of day 0 (open bars), 4 (gray bars), and 8 (black bars) after DSS treatment and from the spleen of day 
0 (hatched bars) are shown. The results represent the means   ±   the SD from six individual mice in each group. *, P   <   0.00 1 (comparison between colonic B 
cells at day 0 versus day 8). (B) Western blot analysis shows the expression levels of NF-    B2 p100 and p52 in purifi  ed B cells (  >  97% are IgM  +  ) of the large 
intestine from 4  –  30 pooled WT mice at day 0 (D0, normal) and 8 (D8, recovery of DSS colitis), and of the spleen from day 0. The data are representative of 
two individual experiments. (C) Expressions of IgM versus CD21 or CD23 on the gated B220  +   cells from normal large intestine of control and BAFF-R mu-
tant mice are shown. (D  –  G) Intestinal infl  ammation was induced in BAFF-R mutant (A/WySnJ; Day 0,   n   = 5; Day 8,   n   = 16) and control (A/J) mice (Day 0, 
  n   = 5; Day 8,   n   = 10) by oral administration of 4% DSS for 4 d. (D and E) Proportion (CD3/IgM; D) and absolute numbers of IgM  +   B cells (E) in the colon of 
control and BAFF-R mutant mice at day 8 of DSS colitis are shown. Presence of statistically signifi  cant (P   <   0.001) compared with control mice at day 8 is 
indicated by **. (F and G) Large intestine from control mice (F) and BAFF-R mutant mice (G) at day 8 were subjected to immunohistochemical analysis for 
the detection of IgM  +   cells. (H) Apoptosis of intestinal IgM  +   B cells in control mice and BAFF-R mutant mice at day 8 of DSS colitis as judged by Annexin V 
staining is shown. The mean percentages of Annexin V  +   cells among IgM  +   cells are 36.6   ±   1.09% in control mice (  n   = 7) and 75.6   ±   1.64% in BAFF-R mu-
tant mice (  n   = 7; P   <   0.001). (I) Expression of AA4.1 versus B220 on the cells from normal intestine of control (left) and BAFF-R mutant (right) are shown. 
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These data suggest that intestinal AA4.1       IgM  +   B cells that are 
constitutively exposed to enteric microorganisms may develop 
or expand through a BCR-independent pathway. 
  Our data demonstrated that intestinal IgM  +   B cells ex-
press remarkably high levels of MHC class II. In contrast, 
several conventional markers expressed on activated splenic B 
cells, were not expressed by intestinal B cells. The unique 
expression profi  le of activation markers was not altered under 
several intestinal infl  ammatory conditions, including sponta-
neous chronic colitis, a chemically induced acute colitis, and 
  Citrobacter rodentium   infection. Therefore, it is possible that 
the intestinal IgM  +   B cell population may represent a unique 
preactivated B cell population presumably caused by the con-
stitutive exposure to enteric microorganisms in the intestine. 
B cells have generally been believed not to produce IL-12p70, 
as this cytokine was detectable only in EBV-transformed B 
cells but not normal systemic B cells (  64  ). However, recent 
accumulating studies have identifi  ed the potential ability of 
B cells to produce IL-12p70 under certain infl  ammatory and 
stimulatory (e.g., combination of CpG and CD40) conditions 
(  41  –  43  ). Interestingly, intestinal IgM  +   B cells showed the 
ability to easily produce IL-12p70 in response to a microbial 
product CpG. Because IL-12p70 is a well known cytokine 
required for safeguarding against microorganisms (  65  ), it is 
possible that the intestinal IgM  +   B cells may contribute to 
preserve appropriate host  –  microbe interaction. 
  In summary, we have identifi  ed an intestine-specifi  c 
AA4.1       CD21       CD23       MHCII  bright   B cell subset that is derived 
from AA4.1  +   immature B cells and from recirculating naive 
B cells. This maturation of these cells represents a distinct path-
way of B cell development that occurs in a tissue site, rather 
than in the BM or the spleen. 
    MATERIALS AND METHODS   
  Mice.     TCR         DKO, RAG-1 KO, IL-7R     KO, Rac2 KO, Lyn KO, Btk 
KO, LT     KO, IghelMD4 Tg, GFP Tg mice of C57BL/6 background, 
BAFF-R mutant (A/WySnJ), and control (A/J) mice were obtained from 
The Jackson Laboratory and maintained in specifi  c pathogen  –  free facilities 
at Massachusetts General Hospital. IghelMD4 Tg mice were crossed with 
RAG1 KO mice as previously described (  40  ) to generate a mouse strain 
that possesses monoclonal B cells. Splenectomy and sham operations were 
performed on anesthetized LT     KO mice at 3 d after birth, as previously 
described (  35  ). Mice were used according to the protocol approved by the 
Massachusetts General Hospital Animal Care and Use Committee. 
  DSS-induced intestinal infl   ammation and   C. rodentium   infection  .     
  Female (10  –  12 wk of age) mice were administered 4% DSS (MW: 36,000  –
  50,000, ICN Biomedicals) in drinking water for 4 d, and the DSS adminis-
tration was then terminated to induce recovery from acute infl  ammation by 
changing the DSS water to normal drinking water as previously described 
(  33  ). These mice were killed on day 0, 4, 8, 14, and 30 after induction of 
DSS-induced acute intestinal infl   ammation. Mice were orally inoculated 
with   C. rodentium   (strain DBS100; American Type Culture Collection), as 
previously described (  66  ). Bacteria were grown overnight in Luria broth and 
resuspended in PBS before infecting mice (0.5 ml/mouse;     5   ×   10  8   CFU of 
  C. rodentium)  . Mice were killed on day 5 and 10 after infection. 
  Cell preparation and B cell isolation.     Large intestine and parts of small 
intestine containing PP were incubated with 1.5 mg/ml dispase to remove 
epithelial cells. The remaining tissues were then incubated with 0.8 mg/ml 
low frequency of SHM, and the ability to secrete IL-12 in 
response to a TLR ligand. This B cell subset exists in the 
normal mucosa of the large intestine and expands in the in-
fl  amed mucosa of mice with acute or chronic colitis. The 
LT    1    2 signaling cascade is required for the development of 
organized lymphoid tissues (such as PP) that provide a site of 
origin of some of IgA  +   plasma cells in small intestine (  17, 18, 
20, 23, 24  ). Most other small intestinal plasma cells originate 
from peritoneal B1 cells (  17, 18, 20, 23, 24, 26  –  28  ). We 
herein describe an additional pathway for intestinal IgM  +   B 
cell development, in which AA4.1       CD21       CD23        B cells in 
the large intestine are supplied from B2 lineage cells that do 
not require organized lymphoid tissues for their develop-
ment. Indeed, recent studies have revealed that some IgM  +   B 
cells in the small intestine are derived from the BM through 
a pathway distinct from that used by gut-primed B cells (  24, 25  ). 
Although the phenotype of BM-derived small intestinal B 
cells has not been characterized in previous studies, it is pos-
sible that the AA4.1       CD21       CD23       MHCII  bright   B cells in the 
large intestine characterized in this study may have a counter-
part in the small intestine. 
  Recirculating B cells mature through transitional stages in 
the spleen, as well as the BM (  2, 3, 5, 8  ). Our BrdU labeling 
and cell transfer studies suggest that intestinal AA4.1       IgM  +   B 
cells can be derived from the AA4.1  +   immature B cell pool. 
In addition, intestinal AA4.1       CD23        B cells were virtually ab-
sent in BAFF-R mutant mice in which development of AA4.1  +   
CD23  +   T2 transitional B cells is defective and T1 transitional/
newly formed B cells accumulate (  61  –  63  ). Therefore, it is 
likely that recirculating T2 B cells that mature from T1 cells 
in the spleen seed the intestinal IgM  +  CD21        B cell compart-
ment in the steady state, down-regulating CD23 when they 
enter the intestinal milieu. Soon after they seed the intestine, 
they may continue to express AA4.1, which is a marker of re-
cent maturation. In addition, CD21       CD23        B cells may ac-
cumulate in the intestine after the recruitment to the infl  amed 
intestine of cells from the recirculating IgD  high   naive B cell pool 
that contains both T2 cells and more mature recirculating fol-
licular B cells. Therefore, it may be inferred that infl  ammatory 
chemokines and cytokines participate in the recruitment of re-
circulating B cells to the intestine during infl  ammation. 
  Peripheral B cell maturation in the spleen and BM depends 
in part on BCR-linked positive selection events (  2, 5, 9  ). 
Interestingly, although infl  ammatory conditions generally in-
duce a restriction of BCR clonality (  12  ), our data showed that 
intestinal AA4.1       IgM  +   B cells polyclonally expand even in the 
presence of intestinal infl  ammation (Fig. S3 and   Fig. 4  ). In addi-
tion, B cells with a restricted BCR expanded readily in normal 
and infl  amed intestine (  Fig. 3  ). Furthermore, T cell help was 
not required for the intestinal AA4.1       IgM  +   B cell develop-
ment. Importantly, a large number of intestinal AA4.1       IgM  +   
B cells were still detectable even in the absence of Btk or Lyn, 
which are major signaling molecules involved in BCR-medi-
ated signaling. In addition, SHM that is often induced in ma-
ture B cells after encounter with specifi  c antigens (  38  ) was 
detectable at very low frequency in the intestinal IgM  +   B cells. JEM VOL. 205, June 9, 2008 
ARTICLE
1353
was performed by MX3000p QPCR machine (Stratagene), and the cDNA con-
centration was normalized as the CT value of     -actin. The normalized cDNA 
samples were subsequently subjected to real-time PCR with Rox dye as a refer-
ence dye for the measurement of expression levels of specifi  c molecules. 
  BCR repertoire.     For DNA sequence of CDR3 within IgM heavy chain, 
cDNA from purifi  ed B cells were amplifi  ed using VHJ558 or V  H  Q52 and 
C     primer set, as previously described (  68  ). The amplifi  ed products were 
cloned using TOPO-TA cloning system. Positive clones that were randomly 
picked up were subjected to DNA sequence. 
  Detection of NF-    B2.     After B cells were positively purifi  ed from spleen 
and colon of pooled mice (4  –  30 mice) under MACS system, purifi  ed IgM  +   
cell (2   ×   10  6  ) B cells were immediately lysed with RIPA buff  er. 3.5   μ  g of 
protein was subjected to immunoblot using rabbit polyclonal anti-p52 (k-27; 
Santa Cruz Biotechnology, Inc.) and anti  –  rabbit HRP (Thermo Fisher Sci-
entifi  c), as previously described (  55  ). 
  Online supplemental material.     Fig. S1 shows the expression of B1 cell 
markers on colonic IgM  +   B cells. Fig. S2 shows the BrdU-incorporated AA4.1  +   
and AA4.1       IgM  +   cells under infl  ammatory condition. Fig. S3 shows BCR 
repertoire (VHJ558) of colonic B cells in steady state and under infl  ammatory 
condition. Fig. S4 shows the BCR repertoire (VHQ52) of colonic B cells in 
steady state and under infl  ammatory condition. The online version of this article 
is available at http://www.jem.org/cgi/content/full/jem.20071572/DC1. 
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collagenase for 20 min. After passing them through a glass wool column, the 
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